IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

RP Management, LLC

Q2 2023 Holdings

Filed 2023-08-11 | 3 holdings | $97.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biohaven LTD(BHVN)COMG1110E107$70.2M2,936,50772.2%
Biocryst Pharmaceuticals Inc(BCRX)COM09058V103$27.1M3,846,15427.8%
Viracta Therapeutics IncCOM92765F108$5.2K3,7000.0%